Company intelligence / Profile preview
Aoxing Pharmaceutical Company, Inc.
Shijiazhuang, Hebei Province, Chinaaxzyen.icm.cn ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
The company has received approval for Tilidine in China (February 2019) and has conducted clinical trials for Codeine Phosphate Compound Medicine for cold and flu treatment. They also received approval for an injectable drug for treating Ischemic Cerebrovascular Disease in December 2008.
- Therapeutic areas
- NeurologyInfectious Diseases
- Modalities
- Small molecule drugs
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
QRxPharma Pty Ltd. (strategic alliance for development of MoxDuo IV)
Beyond the preview
Go deeper on Aoxing Pharmaceutical Company, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aoxing Pharmaceutical Company, Inc..